Carey E Gleason

Summary

Affiliation: University of Wisconsin
Country: USA

Publications

  1. pmc Using predictors of hormone therapy use to model the healthy user bias: how does healthy user status influence cognitive effects of hormone therapy?
    Carey E Gleason
    Division of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin Madison, School of Medicine and Public Health, Madison, WI, USA
    Menopause 19:524-33. 2012
  2. pmc A preliminary study of the safety, feasibility and cognitive efficacy of soy isoflavone supplements in older men and women
    Carey E Gleason
    Section of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin, Madison, WI 53705, USA
    Age Ageing 38:86-93. 2009
  3. ncbi request reprint Neuroprotective effects of female sex steroids in humans: current controversies and future directions
    C E Gleason
    Wm S Middleton Memorial Veterans Hospital, Madison, Wisconsin 53705, USA
    Cell Mol Life Sci 62:299-312. 2005
  4. ncbi request reprint Clinical pharmacology and differential cognitive efficacy of estrogen preparations
    Carey E Gleason
    Department of Medicine, University of Wisconsin Medical School, and Geriatric Research, Education and Clinical Center GRECC, William S Middleton Memorial Veterans Hospital, Madison, WI 53705, USA
    Ann N Y Acad Sci 1052:93-115. 2005
  5. pmc Increased risk for falling associated with subtle cognitive impairment: secondary analysis of a randomized clinical trial
    Carey E Gleason
    Section of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin, Madison, Wisconsin 53705, USA
    Dement Geriatr Cogn Disord 27:557-63. 2009
  6. pmc Hormone effects on fMRI and cognitive measures of encoding: importance of hormone preparation
    C E Gleason
    Section of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin, 2870 University Ave, Suite 106, Madison, WI 53705, USA
    Neurology 67:2039-41. 2006
  7. pmc Awareness of memory abilities in community-dwelling older adults with suspected dementia and mild cognitive impairment
    Feng Lin
    School of Nursing, Department of Medicine, School of Medicine and Public Health, University of Wisconsin Madison, Madison, WI, USA
    Dement Geriatr Cogn Disord 30:83-92. 2010
  8. pmc Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial
    Whitney Wharton
    University of Wisconsin, School of Medicine and Public Health, William S Middleton Memorial VA Hospital, 2500 Overlook Terrace, GRECC11G Madison, WI 53705, USA
    J Alzheimers Dis 26:495-505. 2011
  9. pmc Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review
    Michele L Ries
    William S Middleton Memorial Veterans Hospital Geriatric Research Education and Clinical Center, Madison, Wisconsin 53705, USA
    J Am Geriatr Soc 56:920-34. 2008
  10. ncbi request reprint Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimer's disease
    Cynthia M Carlsson
    Department of Medicine, Section of Geriatrics and Gerontology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA
    J Alzheimers Dis 13:187-97. 2008

Research Grants

Detail Information

Publications22

  1. pmc Using predictors of hormone therapy use to model the healthy user bias: how does healthy user status influence cognitive effects of hormone therapy?
    Carey E Gleason
    Division of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin Madison, School of Medicine and Public Health, Madison, WI, USA
    Menopause 19:524-33. 2012
    ..This study investigated the phenomenon known as the healthy user bias by equating hormone therapy (HT) use (past or current) with healthy user status...
  2. pmc A preliminary study of the safety, feasibility and cognitive efficacy of soy isoflavone supplements in older men and women
    Carey E Gleason
    Section of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin, Madison, WI 53705, USA
    Age Ageing 38:86-93. 2009
    ..Unfortunately, few studies enrolled adults over the age of 70, and none included older men...
  3. ncbi request reprint Neuroprotective effects of female sex steroids in humans: current controversies and future directions
    C E Gleason
    Wm S Middleton Memorial Veterans Hospital, Madison, Wisconsin 53705, USA
    Cell Mol Life Sci 62:299-312. 2005
    ..Further, the paper briefly discusses variables that may account for the unexpected findings of WHIMS, and offers suggestions for future research...
  4. ncbi request reprint Clinical pharmacology and differential cognitive efficacy of estrogen preparations
    Carey E Gleason
    Department of Medicine, University of Wisconsin Medical School, and Geriatric Research, Education and Clinical Center GRECC, William S Middleton Memorial Veterans Hospital, Madison, WI 53705, USA
    Ann N Y Acad Sci 1052:93-115. 2005
    ....
  5. pmc Increased risk for falling associated with subtle cognitive impairment: secondary analysis of a randomized clinical trial
    Carey E Gleason
    Section of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin, Madison, Wisconsin 53705, USA
    Dement Geriatr Cogn Disord 27:557-63. 2009
    ..This study sought to clarify the relationship between subtle cognitive impairment, measured with a widely-used, clinic-based assessment, the Mini Mental State Exam (MMSE), and risk for falls...
  6. pmc Hormone effects on fMRI and cognitive measures of encoding: importance of hormone preparation
    C E Gleason
    Section of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin, 2870 University Ave, Suite 106, Madison, WI 53705, USA
    Neurology 67:2039-41. 2006
    ..These preliminary findings emphasize the need to characterize differential neural effects of various HTs...
  7. pmc Awareness of memory abilities in community-dwelling older adults with suspected dementia and mild cognitive impairment
    Feng Lin
    School of Nursing, Department of Medicine, School of Medicine and Public Health, University of Wisconsin Madison, Madison, WI, USA
    Dement Geriatr Cogn Disord 30:83-92. 2010
    ....
  8. pmc Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial
    Whitney Wharton
    University of Wisconsin, School of Medicine and Public Health, William S Middleton Memorial VA Hospital, 2500 Overlook Terrace, GRECC11G Madison, WI 53705, USA
    J Alzheimers Dis 26:495-505. 2011
    ..Moreover, treatment-related changes in plasma estradiol were positively correlated with improvements in visual memory. Short-term HT that includes the use of estradiol has favorable effects on cognition in women with AD...
  9. pmc Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review
    Michele L Ries
    William S Middleton Memorial Veterans Hospital Geriatric Research Education and Clinical Center, Madison, Wisconsin 53705, USA
    J Am Geriatr Soc 56:920-34. 2008
    ..Third, we will make recommendations regarding the current clinical use of MRI in identification of MCI. As a conclusion, we will look to the future of neuroimaging as a tool in early AD detection...
  10. ncbi request reprint Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimer's disease
    Cynthia M Carlsson
    Department of Medicine, Section of Geriatrics and Gerontology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA
    J Alzheimers Dis 13:187-97. 2008
    ..It is unclear if statins modify Abeta metabolism or improve cognition in asymptomatic middle-aged adults at increased risk for AD...
  11. pmc Cognitive benefits of hormone therapy: cardiovascular factors and healthy-user bias
    Whitney Wharton
    School of Medicine and Public Health, University of Wisconsin, Madison, WI 53705, USA
    Maturitas 64:182-7. 2009
    ..The present observational, community-based, case-controlled study examined the 'healthy-user' bias theory by comparing cognitive task performance in two groups of postmenopausal women, who were either HT users or non-users...
  12. pmc Effect of Alzheimer disease risk on brain function during self-appraisal in healthy middle-aged adults
    Sterling C Johnson
    Geriatric Research Education and Clinical Center, William S Middleton Memorial Veterans Hospital, 2500 Overlook Terrace, Madison, WI 53705, USA
    Arch Gen Psychiatry 64:1163-71. 2007
    ....
  13. pmc The effects of ramipril in individuals at risk for Alzheimer's disease: results of a pilot clinical trial
    Whitney Wharton
    Alzheimer s Disease Research Center, University of Wisconsin, Madison, WI 53705, USA
    J Alzheimers Dis 32:147-56. 2012
    ....
  14. pmc Rationale and design of the Kronos Early Estrogen Prevention Study (KEEPS) and the KEEPS Cognitive and Affective sub study (KEEPS Cog)
    Whitney Wharton
    Department of Medicine, University of Wisconsin, School of Medicine and Public Health, Madison, WI 53792, USA
    Brain Res 1514:12-7. 2013
    ..Here we also describe the most recent results and ongoing HT-related research studies designed to address similar issues. This article is part of a Special Issue entitled Hormone Therapy...
  15. pmc Longer duration of hormonal contraceptive use predicts better cognitive outcomes later in life
    Kelly R Egan
    University of Wisconsin School of Medicine and Public Health, Health Sciences Learning Center, Madison, Wisconsin 53705, USA
    J Womens Health (Larchmt) 21:1259-66. 2012
    ..The aim of this study is to explore the effect of modification of hormone milieu through use of hormonal contraception in premenopausal women and midlife cognitive function...
  16. pmc Anosognosia in mild cognitive impairment: Relationship to activation of cortical midline structures involved in self-appraisal
    Michele L Ries
    Geriatric Research Education and Clinical Center, William S Middleton VA Hospital, Madison, Wisconsin 53705, USA
    J Int Neuropsychol Soc 13:450-61. 2007
    ..This finding highlights the level of anosognosia in MCI as an important predictor of response to self-appraisal in cortical midline structures, brain regions vulnerable to changes in early AD...
  17. pmc A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E epsilon4 allele
    Ryan J Haasl
    Section of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA
    BMC Med Genet 9:37. 2008
    ....
  18. doi request reprint Standardized note template improves screening of firearm access and driving among veterans with dementia
    Noelle K Loconte
    Department of Medicine, Section of Hematology Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA
    Am J Alzheimers Dis Other Demen 23:313-8. 2008
    ..001). In memory assessment clinic, 31.8% had firearms access and 50% were driving. Many patients continued to drive and have access to firearms. The use of templates for the progress note was effective in increasing the screening rate...
  19. pmc Midlife predictors of Alzheimer's disease
    B B Bendlin
    William S Middleton Memorial Veterans Hospital, Geriatric Research Educational and Clinical Center, Madison, WI, USA
    Maturitas 65:131-7. 2010
    ..Here, we review midlife risk factors for AD, and address the potential for therapeutic intervention in midlife...
  20. pmc Activation of brain regions vulnerable to Alzheimer's disease: the effect of mild cognitive impairment
    S C Johnson
    Geriatric Research Education and Clinical Center, Wm S Middleton VA Hospital, 2500 Overlook Terrace 11G, GRECC, Madison, WI 53705, USA
    Neurobiol Aging 27:1604-12. 2006
    ..Our results suggest that a change in function in the PC may account, in part, for memory recollection failure in AD...
  21. pmc Characterization of vascular disease risk in postmenopausal women and its association with cognitive performance
    N Maritza Dowling
    Department of Biostatistics and Medical Informatics, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA
    PLoS ONE 8:e68741. 2013
    ..This study investigated heterogeneity in CV risk factor profiles and its association with demographic, genetic, and cognitive variables...
  22. ncbi request reprint Estrogen and Alzheimer's disease: the story so far
    Brenna Cholerton
    Geriatric Research, Education, and Clinical Center, VA Puget Sound Health Care System, Seattle Tacoma, Washington, USA
    Drugs Aging 19:405-27. 2002
    ..These important issues must be addressed in order to establish the role of estrogen for the prevention and treatment of AD in women...

Research Grants2

  1. Alzheimer's Disease: Potential Benefit of Isoflavones
    Carey Gleason; Fiscal Year: 2007
    ..In addition, blood, collected at each treatment visit, will be assayed for plasma isoflavone levels, and other neuroendocrine markers of interest. ..